Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,766 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

A Study of DXC014 in Patients With Advanced Solid Tumors.

NCT07177937

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Genital Diseases, +28 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 745 locations
View Trial Details
Recruiting

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

NCT06961006

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +11 more
Locations
  • Highlands Oncology Group ( Site 4042) Springdale, Arkansas, United States
  • UCSF Medical Center at Mission Bay ( Site 4044) San Francisco, California, United States
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 4047) Hackensack, New Jersey, United States
  • Inova Schar Cancer Institute ( Site 4046) Fairfax, Virginia, United States
View all 38 locations
View Trial Details
Recruiting

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

NCT06839105

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • The First Affiliated Hospital of Henan University of Science & Technology Luoyang, Henan, China
View all 13 locations
View Trial Details
Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

NCT04895709

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +56 more
Locations
  • Community Cancer Institute Clovis, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of Iowa Iowa City, Iowa, United States
View all 47 locations
View Trial Details
Recruiting

Adjuvant Tebentafusp in High Risk Ocular Melanoma

NCT06246149

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations
  • Northwell Health -Center for Advanced Medicine Lake Success, New York, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Centre Antoine Lacassagne Nice, France
  • Institut Curie - Hôpital de Paris Paris, France
View all 15 locations
View Trial Details

Related conditions